Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACRS

Aclaris Therapeutics

$6.62

-0.2 (-2.93%)

, DERM

Dermira

$9.05

-0.2 (-2.16%)

08:29
03/06/19
03/06
08:29
03/06/19
08:29
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals Analysts…

ACRS

Aclaris Therapeutics

$6.62

-0.2 (-2.93%)

DERM

Dermira

$9.05

-0.2 (-2.16%)

LLY

Eli Lilly

$128.45

0.99 (0.78%)

PFE

Pfizer

$42.89

-0.2 (-0.46%)

REGN

Regeneron

$437.68

3.5 (0.81%)

INCY

Incyte

$85.11

-0.29 (-0.34%)

ANAB

AnaptysBio

$68.82

-1.89 (-2.67%)

GLPG

Galapagos NV

$101.58

-1.14 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 12

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

  • 24

    May

GLPG

Galapagos NV

$97.15

-1.79 (-1.81%)

, PFE

Pfizer

$43.03

-0.04 (-0.09%)

11:52
02/26/19
02/26
11:52
02/26/19
11:52
Recommendations
Galapagos NV, Pfizer analyst commentary at Barclays »

Galapagos weakness could…

GLPG

Galapagos NV

$97.15

-1.79 (-1.81%)

PFE

Pfizer

$43.03

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    May

GLPG

Galapagos NV

$97.83

-3.2 (-3.17%)

09:00
02/22/19
02/22
09:00
02/22/19
09:00
Initiation
Galapagos NV initiated at SVB Leerink »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Over a month ago
GLPG

Galapagos NV

$103.40

2.56 (2.54%)

16:32
01/08/19
01/08
16:32
01/08/19
16:32
Hot Stocks
Sands Capital reports 5.7% stake in Galapagos »

Pursuant to Belgian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

  • 22

    Feb

GLPG

Galapagos NV

$97.46

7.96 (8.89%)

16:20
01/06/19
01/06
16:20
01/06/19
16:20
Hot Stocks
Galapagos initiates NOVESA Phase 2a trial in patients with systemic sclerosis »

Galapagos NV expands its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 22

    Feb

GLPG

Galapagos NV

$97.18

7.68 (8.58%)

16:02
01/04/19
01/04
16:02
01/04/19
16:02
Hot Stocks
Galapagos, Fibrocor sign partnership in fibrosis »

Fibrocor Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Over a quarter ago
GILD

Gilead

$64.82

-0.33 (-0.51%)

, GLPG

Galapagos NV

$97.88

-3.85 (-3.78%)

06:58
12/19/18
12/19
06:58
12/19/18
06:58
Recommendations
Gilead, Galapagos NV analyst commentary at Cantor Fitzgerald »

Gilead price target…

GILD

Gilead

$64.82

-0.33 (-0.51%)

GLPG

Galapagos NV

$97.88

-3.85 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$97.88

-3.85 (-3.78%)

06:55
12/19/18
12/19
06:55
12/19/18
06:55
Initiation
Galapagos NV initiated at Cantor Fitzgerald »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$101.73

-2.44 (-2.34%)

16:23
12/17/18
12/17
16:23
12/17/18
16:23
Hot Stocks
Galapagos NV initiates ISABELA Phase 3 program »

Galapagos NV announced …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

, ABBV

AbbVie

$88.62

0.45 (0.51%)

08:14
12/13/18
12/13
08:14
12/13/18
08:14
Upgrade
Galapagos NV, AbbVie rating change  »

Galapagos NV upgraded to…

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

ABBV

AbbVie

$88.62

0.45 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.